Test Article
|
Matrix
|
Species
|
Anticoagulant
|
Assay Type
|
LLOQ-ULOQ
|
25-O-Desacetylrifabutin |
Plasma |
Human |
Heparin |
LC-MS/MS |
1-1000 |
3,4-Dihydroxyphenylacetic Acid |
Cerebrospinal Fluid |
Human |
None |
LC-EC |
0.1-40 |
3,4-Dihydroxyphenylacetic Acid |
Plasma |
Human |
EDTA |
LC-EC |
|
3,4-Dihydroxyphenylglycol |
Cerebrospinal Fluid |
Human |
None |
LC-EC |
0.1-10 |
3,4-Dihydroxyphenylglycol |
Plasma |
Human |
EDTA |
LC-EC |
0.5-4.5 |
3-Methoxytyramine |
Cerebrospinal Fluid |
Human |
None |
LC-MS/MS |
0.05-5 |
3-O-Methyldopa |
Plasma |
Human |
EDTA |
LC-EC |
5-250 |
4-Hydroxycyclophosphamide |
Plasma |
Human |
Heparin |
LC-MS/MS |
5-500 |
4-Ketocyclophosphamide |
Plasma |
Human |
Heparin |
LC-MS/MS |
0.1-10 |
5-Fluorouracil |
Plasma |
Human |
EDTA/Heparin |
LC-MS/MS |
10-10000 |
6-Sulfatoxymelatonin Sulfate |
Urine |
Human |
None |
LC-MS/MS |
0.2-200 |
6β-Hydroxycortisol |
Urine |
Human |
None |
LC-MS/MS |
1-1000 |
6β-Hydroxycortisol |
Urine |
Human |
None |
LC-MS/MS |
10-2000 |
Abiraterone |
Plasma |
Human |
EDTA/Heparin |
LC-MS/MS |
0.5-420 |
Acetaminophen |
Plasma |
Human |
EDTA |
LC-MS/MS |
4-2000 |
Acetaminophen |
Plasma |
Human |
EDTA |
MS |
4-2000 |
Acetylsalicylic Acid |
Plasma |
Dog |
EDTA |
LC-MS/MS |
5-500 |
Acetylsalicylic Acid |
Plasma |
Dog |
Sodium Fluoride and Potassium Oxalate |
LC-MS/MS |
50-15000 |
Acetylsalicylic Acid |
Plasma |
Human |
EDTA |
LC-UV |
100 |
Active Glucagon-Like Peptide-1 (GLP-1) |
Plasma |
Human |
EDTA |
ELISA-ECL |
0.002-2.5 |
Adiponectin |
Serum |
Human |
None |
ELISA |
5-300 |
Alprazolam and Hydroxyalprazolam Metabolites |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.3-1000 |
Amiodarone and Desethylamiodarone |
Plasma |
Human |
EDTA |
LC-MS/MS |
5-3000 |
Aripiprazole |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.1-100 |
Artesunate |
Plasma |
Human |
Heparin |
LC-MS/MS |
10-2000 |
Atropine |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.05-250 |
Azithromycin |
Plasma |
Human |
Heparin |
LC-EC |
12.5-1000 |
Azithromycin |
Serum |
Human |
None |
LC-EC |
10.4-1000 |
Baclofen |
Plasma |
Human |
Heparin |
LC-MS/MS |
20-1000 |
Bendamustine and M3 and M4 Metabolites |
Plasma |
Human |
Heparin |
LC-MS/MS |
1-1000 |
Benzophenone |
Plasma |
Human |
EDTA |
LC-MS/MS |
5-5000 |
Bortezomib |
Plasma |
Human |
Heparin |
LC-MS/MS |
1-250 |
Bupivacaine |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.5-500 |
C-Reactive Protein |
Serum |
Porcine |
None |
ELISA |
3-100 |
Caffeine |
Plasma |
Human |
EDTA |
LC-MS/MS |
25-20000 |
Capecitabine and Metabolites (Prodrug for 5-Fluorouracil) |
Plasma |
Human |
Heparin |
LC-MS/MS |
75-10000 |
Carbamazepine and Carbamazepine-10,11-Epoxide |
Plasma |
Human |
EDTA |
LC-MS/MS |
5-5000 |
Carbidopa |
Plasma |
Human |
EDTA |
LC-EC |
10-2000 |
Carbidopa |
Plasma |
Human |
EDTA |
LC-EC |
10-2000 |
Chlorhexidine |
Plasma |
Rabbit |
EDTA |
LC-MS/MS |
0.5-50 |
Chlorpheniramine |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.2-50 |
Chlorpheniramine |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.2-100 |
Ciprofloxacin |
Plasma |
Human |
EDTA |
LC-MS/MS |
100-10000 |
Clonazepam |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.100-100 |
Clonidine |
Plasma |
Rat |
EDTA |
LC-MS/MS |
5-5000 |
Cortisol |
Urine |
Human |
None |
LC-MS/MS |
5-1000 |
Cortisol |
Urine |
Human |
None |
LC-MS/MS |
0.5-500 |
Cortisol |
Urine |
|
None |
LC-MS/MS |
1-500 |
Cyanide |
Whole Blood (Lysed) |
Human |
EDTA |
LC-MS/MS |
25-2500 |
Cyclophosphamide |
Plasma |
Human |
Heparin |
LC-MS/MS |
250-25000 |
Cyclophosphamide |
Plasma |
Human |
Heparin |
LC-MS/MS |
1-100 |
Darunavir |
Plasma |
Human |
EDTA |
LC-MS/MS |
25-12500 |
Daunorubicin |
Plasma |
Human |
EDTA |
LC-MS/MS |
1-1000 |
Dechloroethylcyclophosphamide |
Plasma |
Human |
Heparin |
LC-MS/MS |
0.1-10 |
Dehydroaripiprazole |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.1-100 |
Delta-9-Tetrahydrocannabinol (THC) and 11-Hydroxy Metabolite |
Plasma |
Human |
Heparin |
LC-MS/MS |
0.05-50 |
Desipramine |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.2-100 |
Dexamethasone |
Endocardial and Myocardial Tissue |
Dog |
None |
LC-MS/MS |
1-1000 |
Dexamethasone |
Plasma |
Dog |
EDTA |
LC-MS/MS |
0.001-100 |
Dexamethasone |
Plasma |
Porcine |
EDTA |
LC-MS/MS |
0.1-100 |
Dexamethasone Phosphate |
Plasma |
Rabbit |
EDTA |
LC-MS/MS |
0.2-200 |
Dihydroartemisinin |
Plasma |
Human |
Heparin |
LC-MS/MS |
10-2000 |
Diltiazem |
Plasma |
Human |
Heparin |
LC-MS/MS |
1-500 |
Diltiazem |
Plasma |
Dog |
EDTA |
LC-MS/MS |
0.05-50 |
Diltiazem |
Plasma |
Rat |
Heperain |
LC-MS/MS |
1-500 |
Dipeptidylpeptidase IV (DPP IV) |
Plasma |
Human |
Citrate |
Fluorimetric Enzyme |
Enzyme |
Docetaxel |
Plasma Ultrafiltrate |
Human |
Heparin |
LC-MS/MS |
2-100 |
Docetaxel |
Plasma |
Human |
EDTA/Heparin |
LC-MS/MS |
1-1000 |
Docetaxel |
Plasma Ultrafiltrate |
Human |
Heparin |
LC-MS/MS |
2-100 |
Docetaxel |
Plasma |
Human |
Heparin |
LC-MS/MS |
1-1000 |
Docetaxel |
Plasma |
Mouse |
Heparin |
LC-MS/MS |
50-5000 |
Docetaxel |
Plasma |
Dog |
Heparin |
LC-MS/MS |
10-2500 |
Docetaxel |
Plasma |
Human |
Heparin |
LC-MS/MS |
10-2500 |
Docetaxel |
Plasma |
Human |
Heparin |
LC-MS/MS |
10 |
Donepezil |
Plasma |
Porcine |
EDTA |
LC-MS/MS |
0.03-10 |
Donepezil |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.1-100 |
Dopamine |
Plasma |
Human |
EDTA |
LC-MS/MS |
2-1000 |
Doxorubicin |
Plasma |
Human |
EDTA |
LC-MS/MS |
1-1000 |
Efavirenz |
Plasma |
Human |
Heparin |
LC-MS/MS |
200-10000 |
Efavirenz |
Plasma |
Human |
EDTA/Heparin |
LC-MS/MS |
200-10000 |
Eicosapentaenoic acid |
Plasma |
Human |
None |
LC-MS/MS |
400-45000 |
Eletriptan |
Plasma |
Human |
Heparin |
LC-MS/MS |
0.5-250 |
Emtricitabine |
Plasma |
Human |
EDTA |
LC-MS/MS |
5-500 |
Epinephrine |
Plasma |
Human |
EDTA |
LC-EC |
100-2000 |
Epinephrine |
Cerebrospinal Fluid |
Human |
None |
LC-EC |
0.1-10 |
Erythromycin |
Plasma |
Human |
Heparin |
LC-MS/MS |
10-10000 |
Ethinyl Estradiol |
Plasma |
Human |
EDTA |
LC-MS/MS |
5-500 |
Everolimus |
Whole Blood |
Human |
EDTA |
LC-MS/MS |
0.25-250 |
Everolimus |
Whole Blood |
Porcine |
EDTA |
LC-MS/MS |
0.1-100 |
Everolimus |
Tissues |
Porcine |
None |
LC-MS/MS |
0.5-500 |
Fenofibric Acid |
Plasma |
Mouse |
EDTA |
LC-MS/MS |
1-1000 |
Fentanyl |
Serum |
Human |
None |
LC-MS/MS |
0.05-10 |
Fentanyl |
Serum |
Human |
None |
LC-MS/MS |
0.05-10 |
Fluconazole |
Plasma |
Human |
EDTA |
LC-MS/MS |
10-10000 |
Gabapentin |
Plasma |
Human |
Heparin |
LC-MS/MS |
2-10000 |
Gemcitabine |
Plasma |
Human |
EDTA |
LC-MS/MS |
1-1000 |
Gemcitabine and 2’,2’-Difluoro-2’-Deoxyuridine (dFdU) Metabolite |
Plasma (THU-treated) |
Human |
Heparin |
LC-MS/MS |
50-50000 |
Gemfibrozil |
Plasma |
Human |
EDTA |
LC-MS/MS |
50-50000 |
Genistein |
Serum |
Human |
None |
LC-MS/MS |
1-1000 |
Glimepiride |
Serum |
Human |
N/A |
LC-MS/MS |
1-500 |
Glycinexylidide |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.5-50 |
Granisetron |
Plasma |
Human and Dog |
EDTA |
LC-MS/MS |
1-1000 |
Guanethidine |
Plasma |
Porcine |
EDTA |
LC-MS/MS |
1-1000 |
Haptoglobin |
Serum |
Porcine |
None |
ELISA |
6.25-400 |
Homovanillic Acid |
Cerebrospinal Fluid |
Human |
None |
LC-MS/MS |
5-500 |
Homovanillic Acid |
Plasma |
Human |
EDTA |
LC-EC |
5-250 |
Hydrochlorothiazide |
Plasma |
Human |
EDTA |
LC-MS/MS |
1-500 |
Hydrochlorothiazide |
Urine |
Human |
None |
LC-MS/MS |
100-10000 |
Hydrochlorothiazide |
Dried Whole Blood |
Human |
None |
LC-MS/MS |
1-500 |
Hydrocodone |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.2-100 |
Hydrocodone |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.2-100 |
Hydroxymidazolam |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.3-300 |
Hydroxymidazolam |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.3-300 |
Iopromide |
Plasma & Tissue |
Porcine |
EDTA |
LC-MS/MS |
1-1000, 100-30000 |
Ivermectin H2B1a |
Plasma |
Human |
Heparin |
LC-MS/MS |
2.5-1000 |
Ivermectin H2B1b |
Plasma |
Human |
Heparin |
LC-MS/MS |
2.5-20 |
Ketoconazole and Fluconazole |
Plasma |
Human |
EDTA |
LC-MS/MS |
10-10000 |
Ketoprofen |
Plasma |
Rat |
EDTA |
LC-MS/MS |
1-1000 |
Ketoprofen |
Plasma |
Porcine |
EDTA |
LC-MS/MS |
1-1000 |
Lenalidomide |
Plasma |
Human |
EDTA |
LC-MS/MS |
1-1000 |
Levodopa |
Plasma |
Human |
EDTA |
LC-EC |
10-2000 |
Levodopa |
Cerebrospinal Fluid |
Human |
None |
LC-EC |
0.1-10 |
Levodopa |
Plasma |
Human |
EDTA |
LC-EC |
10-2000 |
Levodopa |
Plasma |
Human |
EDTA |
LC-MS/MS |
2-1000 |
Levofloxacin |
Plasma |
Human |
EDTA |
LC-MS/MS |
10-10000 |
Levonorgestrel |
Plasma |
Human |
EDTA |
LC-MS/MS |
100-10000 |
Lidocaine |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.5-50 |
Lisinopril |
Plasma |
Human |
Heparin |
LC-MS/MS |
1-500 |
Lorazepam |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.3-100 |
Melatonin |
Saliva |
Human |
none |
ELISA |
0.6-25 |
Melatonin |
Plasma |
Human |
EDTA |
LC-MS/MS |
1-100 |
Melatonin |
Saliva |
Human |
None |
LC-MS/MS |
0.001-0.1 |
Metformin |
Plasma |
Human |
EDTA |
LC-MS/MS |
20-5000 |
Metformin |
Serum |
Human |
None |
LC-MS/MS |
10-3500 |
Methotrexate and 7-Hydroxymethotrexate Metabolite |
Plasma |
Human |
Heparin |
LC-MS/MS |
1-1000 |
Methotrexate and 7-Hydroxymethotrexate Metabolite |
Urine |
Human |
None |
LC-MS/MS |
20-10000 |
Methylphenidate |
Plasma |
Rat |
EDTA |
LC-MS/MS |
5-5000 |
Metoprolol and Alpha-Hydroxy Metoprolol Metabolite |
Plasma |
Human |
Heparin |
LC-MS/MS |
5-500 |
Midazolam |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.3-300 |
Midazolam |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.3-300 |
Monoethylglycinexlidide |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.5-50 |
Montelukast |
Plasma |
Human |
Heparin |
LC-MS/MS |
1.25-1250 |
Morphine |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.02-10 |
Morphine and Metabolites |
Plasma |
Human or Dog |
EDTA |
LC-MS/MS |
1-500 |
Morphine-6β-D-Glucuronide |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.1-50 |
Muraglitazar |
Plasma |
Mouse |
EDTA |
LC-MS/MS |
1-1000 |
Mycophenolic Acid |
Plasma |
Human |
Heparin |
LC-MS/MS |
50-10000 |
Naloxone |
Plasma |
Human |
EDTA |
LC-MS/MS |
1-200 |
Naproxen |
Plasma |
Human |
Heparin |
LC-MS/MS |
100-100000 |
Naproxen (on-line extraction) |
Plasma |
Human |
Heparin |
LC-MS/MS |
100-100000 |
Nicotine |
Plasma |
Human |
EDTA |
LC-MS/MS |
2-200 |
Nitrite |
Plasma |
Rabbit |
None |
LC-FL |
250-8000 |
Nitrite |
Plasma |
Rat |
Heparin |
LC-FL |
250-8000 |
Nitrite |
Plasma |
Dog |
Heparin |
LC-FL |
200-8000 |
Nitrite |
Plasma |
Human |
Heparin |
LC-FL |
15-1200 |
Nitrite |
Plasma |
Human |
Heparin |
LC-FL |
150-8000 |
Nordiazepam |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.3-300 |
Norepinephrine |
Cerebrospinal Fluid |
Human |
None |
LC-MS/MS |
0.1-10 |
Norepinephrine |
Plasma |
Human |
EDTA |
LC-EC |
0.25-2.25 |
Norepinephrine |
Plasma |
Human |
EDTA |
LC-EC |
150-3000 |
Noroxycodone |
Plasma |
Human |
EDTA |
LC-MS/MS |
1-100 |
Noroxycodone |
Plasma |
Plasma |
EDTA |
LC-MS/MS |
0.1-100 |
Norquetiapine |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.5-500 |
Octenidine |
Plasma |
Human |
EDTA |
LC-MS/MS |
1-10 |
Octenidine |
Plasma |
Mini Pig |
EDTA |
LC-MS/MS |
1-10 |
Olanzapine and N-Desmethyl Olanzapine Metabolite |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.1-100 |
Omeprazole |
Plasma |
Human |
Heparin |
LC-MS/MS |
10-1000 |
Ondansetron |
Urine |
Human |
None |
LC-MS/MS |
0.2-2000 |
Ondansetron |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.2-2000 |
Ondansetron |
Dried Whole Blood |
Human |
None |
LC-MS/MS |
0.2-100 |
Ondansetron |
Plasma |
Human or Dog |
EDTA |
LC-MS/MS |
1-1000 |
Oseltamivir |
Plasma |
Human |
Heparin |
LC-MS/MS |
1-250 |
Oseltamivir Carboxylate |
Plasma |
|
Heparin |
LC-MS/MS |
10-10000 |
Oxycodone |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.1-100 |
Oxycodone |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.1-100 |
Oxymorphone |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.1-100 |
Oxymorphone |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.1-100 |
Oxymorphone and 6β-Hydroxyoxymorphone Metabolite |
Plasma |
Human |
EDTA |
LC-MS/MS |
20-2000 |
Paclitaxel |
Seminal Fluid |
Human |
None |
LC-MS/MS |
0.1-100 |
Paclitaxel |
Urine |
Human |
None |
LC-MS/MS |
0.1-100 |
Paclitaxel |
Plasma |
Dog |
Heparin |
LC-MS/MS |
0.1-100 |
Paclitaxel |
Urethral and Prostate Tissues |
Dog |
None |
LC-MS/MS |
0.3-300 |
Paclitaxel |
Urethral and Prostate Tissues |
Dog |
None |
LC-MS/MS |
0.3-400 |
Paclitaxel |
Plasma |
Human |
EDTA |
LC-MS/MS |
5-5000 |
Paclitaxel |
Plasma |
Rat |
Heparin |
LC-MS/MS |
0.1-100 |
Paclitaxel |
Arterial Tissue |
Porcine |
None |
LC-MS/MS |
0.5-500 |
Paclitaxel |
Plasma |
Human |
Heparin |
LC-MS/MS |
20-5000 |
Paclitaxel |
Seminal Fluid |
Human |
None |
LC-MS/MS |
0.1-100 |
Paclitaxel |
Plasma Ultrafiltrate |
Dog |
EDTA |
LC-MS/MS |
0.3-1000 |
Paclitaxel |
Serum |
Porcine |
None |
LC-MS/MS |
0.03-30 |
Paclitaxel |
Whole Blood |
Dog |
Heparin |
LC-MS/MS |
1-1000 |
Paclitaxel |
Whole Blood |
Porcine |
None |
LC-MS/MS |
0.03-30 |
Paclitaxel |
Urine |
Porcine |
None |
LC-MS/MS |
0.03-30 |
Paclitaxel |
Plasma |
Porcine |
EDTA/Heparin |
LC-MS/MS |
0.03-30 |
Paclitaxel |
Whole Blood |
Human |
None |
LC-MS/MS |
1-1000 |
Paclitaxel |
Plasma or Plasma Ultrafiltrate |
Human |
EDTA/Heparin |
LC-MS/MS |
0.1-1000 |
Paclitaxel |
Serum |
Mouse |
None |
LC-MS/MS |
0.3-300 |
Paclitaxel |
Serum |
Dog |
None |
LC-MS/MS |
0.03-30 |
Paclitaxel |
Plasma |
Dog |
Heparin |
LC-MS/MS |
0.1-100 |
Paclitaxel |
Serum |
Porcine |
None |
LC-MS/MS |
0.03-100 |
Paclitaxel |
Tissues |
Porcine |
None |
LC-MS/MS |
0.3-500 |
Paclitaxel |
Plasma |
Rabbit |
EDTA/Heparin |
LC-MS/MS |
0.03-30 |
Paclitaxel |
Serum |
Rabbit |
None |
LC-MS/MS |
0.03-30 |
Paclitaxel and 6α-Hydroxy Paclitaxel Metabolite |
Plasma |
Human |
EDTA |
LC-MS/MS |
1-1000 |
Paclitaxel, 3-OH-Paclitaxel, & 6-OH-Paclitaxel |
Dog & Rat Plasma |
|
Heparin |
LC-MS/MS |
0.100 |
Paraxanthine (1,7-Dimethylxanthine) |
Plasma |
Human |
EDTA |
LC-MS/MS |
25-20000 |
Paroxetine |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.1-60 |
Phentermine |
Plasma |
Human |
Heparin |
LC-MS/MS |
2.5-500 |
Pioglitazone |
Plasma |
Human |
EDTA |
LC-MS/MS |
25-2500 |
Pioglitazone |
Urine |
Human |
None |
LC-MS/MS |
1-1000 |
Pioglitazone |
Serum |
Human |
None |
LC-MS/MS |
25-2500 |
Pioglitazone, Pioglitazone MIII, Pioglitazone MIV |
Plasma |
Human |
EDTA |
LC-MS/MS |
1-1000 |
Pioglitazone-MIII and -MIV |
Plasma |
Human |
EDTA |
LC-MS/MS |
2.5-2500 |
Pioglitazone-MIII and -MIV |
Urine |
Human |
None |
LC-MS/MS |
2.5-2500 |
Pioglitazone-MIII and -MIV |
Plasma |
Human |
EDTA |
LC-MS/MS |
25-2500 |
Propofol |
Human Plasma |
|
EDTA |
LC-UV |
100-15000 |
Pseudoephedrine |
Plasma |
Human |
EDTA |
LC-MS/MS |
5-2500 |
Pseudoephedrine |
Plasma |
Human |
EDTA |
LC-MS/MS |
50-1000 |
Quetiapine |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.5-500 |
Quetiapine Sulfoxide |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.5-500 |
Raltegravir |
Plasma |
Human |
EDTA/Heparin |
LC-MS/MS |
2-1000 |
Rapamycin |
Whole Blood (Lysed) |
Dog |
EDTA |
LC-MS/MS |
0.1-100 |
Rapamycin |
Arterial Tissue |
Porcine |
None |
LC-MS/MS |
50-5000 |
Rapamycin |
Arterial Tissue |
Porcine |
None |
LC-MS/MS |
0.2-100 |
Rapamycin |
Whole Blood (Lysed) |
Cat |
EDTA |
LC-MS/MS |
0.1-100 |
Rapamycin |
Whole Blood (Lysed) |
Monkey |
EDTA |
LC-MS/MS |
0.1-100 |
Rapamycin |
Whole Blood (Lysed) |
Monkey |
EDTA |
LC-MS/MS |
1000-40000 |
Rapamycin |
Arterial Tissue |
Porcine |
None |
LC-MS/MS |
0.1-50 |
Rapamycin |
Myocardial Tissue |
Porcine |
None |
LC-MS/MS |
0.5-500 |
Rapamycin |
Arterial Tissue |
Porcine |
None |
LC-MS/MS |
0.5-500 |
Rapamycin |
Whole Blood |
Porcine |
EDTA |
LC-MS/MS |
0.1-100 |
Rapamycin |
Liver Tissue |
Porcine |
None |
LC-MS/MS |
0.5-500 |
Rapamycin |
Kidney Tissue |
Porcine |
None |
LC-MS/MS |
0.5-500 |
Rapamycin |
Lung Tissue |
Porcine |
None |
LC-MS/MS |
0.5-500 |
Rapamycin |
Tissues |
Porcine |
None |
LC-MS/MS |
0.5-500 |
Rapamycin |
Whole Blood (Lysed) |
Porcine |
EDTA |
LC-MS/MS |
0.1-100 |
Rapamycin |
Whole Blood |
Human |
EDTA |
LC-MS/MS |
0.1-100 |
Renzapride |
Plasma |
Human |
EDTA/Heparin |
LC-MS/MS |
0.1-10 |
Ribavirin |
Plasma |
Rat |
EDTA |
LC-MS/MS |
10-5000 |
Ribavirin |
Plasma |
Rat |
EDTA |
LC-MS/MS |
10-5000 |
Rifabutin |
Plasma |
Human |
Heparin |
LC-MS/MS |
1-1000 |
Rifampin |
Plasma |
Rabbit |
Heparin |
LC-MS/MS |
2.5-100 |
Rimonabant |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.1-100 |
Risperidone and 9-Hydroxyrisperidone Metabolite |
Plasma |
Human |
Heparin |
LC-MS/MS |
0.1-100 |
Ritonavir |
Plasma |
Human |
EDTA |
LC-MS/MS |
25-12500 |
Rizatriptan |
Plasma |
Human |
Heparin |
LC-MS/MS |
0.3-100 |
Salicylic Acid |
Plasma |
Dog |
EDTA |
LC-MS/MS |
50-5000 |
Salicylic Acid |
Plasma |
Dog |
Sodium Fluoride and Potassium Oxalate |
LC-MS/MS |
500-150000 |
Scopolamine |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.01-20 |
Serum Amyloid-A |
Serum |
Porcine |
None |
ELISA |
125-2000 |
Sildenafil and N-Desmethyl Sildenafil Metabolite |
Plasma |
Human |
Heparin |
LC-MS/MS |
1-500 |
Simvastatin & Simvastatin β-hydroxy Acid Metabolite |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.05-10 |
Simvastatin and Simvastatin Hydroxy Acid Metabolite |
Plasma |
v |
EDTA |
LC-MS/MS |
0.05-100 |
Sitagliptin |
Urine |
Human |
None |
LC-MS/MS |
1-1000 |
Spironolactone |
Plasma |
Human |
Heparin |
LC-MS/MS |
1-1000 |
Sumatriptan |
Plasma |
Human |
Heparin |
LC-MS/MS |
0.5-500 |
Sunitinib and N-desethyl Sunitinib |
Plasma |
v |
EDTA |
LC-MS/MS |
1-100 |
Tacrolimus |
Whole Blood |
Human |
EDTA |
LC-MS/MS |
0.1-100 |
Tacrolimus |
Whole Blood |
Human |
EDTA |
LC-MS/MS |
0.1-100 |
Tamoxifen |
Plasma |
Human |
Heparin |
LC-MS/MS |
0.5-500 |
Temozolomide |
Plasma |
Rat |
Heparin |
LC-MS/MS |
10-2000 |
Tenofovir |
Plasma |
Human |
EDTA |
LC-MS/MS |
5-500 |
Tesaglitazar |
Plasma |
Mouse |
EDTA |
LC-MS/MS |
1-1000 |
Testosterone |
Plasma and Serum |
Porcine |
EDTA |
LC-MS/MS |
0.1-20 |
Theophylline |
Plasma |
Human |
Heparin |
LC-UV |
300-20000 |
Tiagabine |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.5-500 |
Tissue Plasminogen Activator (tPA or PLAT) |
Plasma |
Rabbit |
EDTA |
ELISA |
15.6-500 |
Total Glucagon-Like Peptide-1 (GLP-1) |
Plasma |
Human |
EDTA |
ECL |
2.44-2500 |
Total Glucagon-Like Peptide-1 (GLP-1) |
Plasma |
Human |
EDTA |
ELISA |
2-100 |
Total Protein Content |
White Blood Cell Lysate |
Human |
None |
Spectrometer |
150-2000 |
Total Protein Content |
White Blood Cell Lysate |
Human |
None |
Spectrometer |
25-2000 |
Warfarin (R and S enantiomers separated) |
Plasma |
Human |
Heparin |
LC-MS/MS |
1-1000 |
Ziprasidone |
Plasma |
Human |
EDTA |
LC-MS/MS |
0.2-200 |